Position in ACHV
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$252,510
-$174,353 QoQ
Shares Held
85,888
0.0% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#25
of 81 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACHV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Blue Trust, Inc. holds $4,223,843 across 69 Biotechnology names. ACHV ranks #6 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
15,939 | $683,623 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
772 | $596,478 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
3,003 | $567,716 | |
| 4 | DMAC |
DiaMedica Therapeutics Inc.
|
69,122 | $467,955 | |
| 5 | GMAB |
Genmab A/S
|
11,609 | $311,468 | |
| 6 | ACHV |
Achieve Life Sciences, Inc.
This page
|
85,888 | $252,510 | |
| 7 | ONC |
BeOne Medicines Ltd.
|
826 | $245,296 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
425 | $189,779 |
All Filings in ACHV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $252,510 | 85,888 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $426,863 | 85,888 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $312,259 | 99,130 | Shares | Sole | 2025-10-16 | |
| No filing history on record for this holder in this stock. | ||||||